Division of Medicine and Therapeutics, University of Dundee, UK.
Clin Endocrinol (Oxf). 2008 Feb;68(2):311-6. doi: 10.1111/j.1365-2265.2007.03051.x. Epub 2007 Oct 29.
We aimed to describe the changing incidence of thyroid disease in a population-based study in Tayside, Scotland (population 390 000) between 1994 and 2001.
A retrospective, data-linkage, population-based study measuring the incidence and prevalence of thyroid disease.
All patients with newly diagnosed, treated and stable thyroid disease in Tayside were identified by electronic linkage of six datasets, including all regional biochemistry data, hospital admissions, deaths and a thyroid follow-up register.
The overall prevalence of thyroid dysfunction has increased from 2.3% to 3.8% (1994-2001). The prevalence of ever having had hyperthyroidism increased from 0.86% to 1.26% in females and 0.17% to 0.24% in males (P < 0.0001 for both). The standardized incidence of hyperthyroidism increased from 0.68 to 0.87 per 1000 females/year, representing a 6.3% annual increase (P < 0.0001). The prevalence of primary hypothyroidism increased from 3.12% to 5.14% in females and 0.51% to 0.88% in males (P < 0.0001 for both). The standardized incidence of primary hypothyroidism did not change and varied between 3.90 and 4.89 per 1000 females/year over the 8 years. Incidence of hypothyroidism in males increased from 0.65 to 1.01 per 1000 males/year (P = 0.0017). Mean age at diagnosis of primary hypothyroidism declined in females from 1994 to 2001.
The prevalence of primary hypothyroidism and previous hyperthyroidism has increased in Tayside, Scotland. This is partly due to an increasing incidence of disease, increased ascertainment and earlier diagnosis of disease. This will result in an increased workload for endocrinologists and general practitioners.
我们旨在描述在苏格兰泰赛德地区(人口 390000)进行的一项基于人群的研究中,1994 年至 2001 年间甲状腺疾病的发病率变化。
一项回顾性、数据链接、基于人群的研究,用于测量甲状腺疾病的发病率和患病率。
通过电子链接六个数据集,包括所有区域生化数据、住院、死亡和甲状腺随访登记册,确定了泰赛德地区所有新诊断、治疗和稳定的甲状腺疾病患者。
总体甲状腺功能障碍的患病率从 2.3%增加到 3.8%(1994-2001 年)。女性中既往患有甲状腺功能亢进症的患病率从 0.86%增加到 1.26%,男性中从 0.17%增加到 0.24%(均<0.0001)。女性每 1000 人/年的甲状腺功能亢进症标准化发病率从 0.68 增加到 0.87,年增长率为 6.3%(<0.0001)。女性原发性甲状腺功能减退症的患病率从 3.12%增加到 5.14%,男性从 0.51%增加到 0.88%(均<0.0001)。8 年内,女性每 1000 人/年的原发性甲状腺功能减退症标准化发病率没有变化,在 3.90 至 4.89 之间。男性甲状腺功能减退症的发病率从 0.65 增加到 1.01 每 1000 男性/年(P=0.0017)。女性原发性甲状腺功能减退症的平均诊断年龄从 1994 年到 2001 年下降。
苏格兰泰赛德地区原发性甲状腺功能减退症和既往甲状腺功能亢进症的患病率增加。这部分是由于疾病发病率的增加、疾病检出率的提高和疾病的早期诊断。这将导致内分泌学家和全科医生的工作量增加。